Biblio
Export 165 results:
Author Title Type [ Year
Filters: First Letter Of Title is R [Clear All Filters]
“Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1519-1528, 2017.
, “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
, “Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 483-493, 2017.
, “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
, “The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1429-1435, 2017.
, “The Role of ADAM10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 2, pp. 303-322, 2017.
, “The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 381-389, 2017.
, “Role of Glutamate and NMDA Receptors in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1041-1048, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.”, J Alzheimers Dis, vol. 59, no. 3, pp. 785-795, 2017.
, “Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.”, J Alzheimers Dis, vol. 53, no. 2, pp. 705-12, 2016.
, “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
, “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
, “Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.”, J Alzheimers Dis, vol. 52, no. 2, pp. 403-16, 2016.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”, J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
, “Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1147-1155, 2016.
, “Reliability and Validity of a Novel Internet-Based Battery to Assess Mood and Cognitive Function in the Elderly.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1359-1364, 2016.
, “Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China.”, J Alzheimers Dis, vol. 49, no. 1, pp. 139-47, 2016.
, “Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 127-31, 2016.
, “Retinal oximetry imaging in Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.
, “Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1443-58, 2016.
, “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
,